Page last updated: 2024-11-03

propranolol and Abstinence Syndrome, Neonatal

propranolol has been researched along with Abstinence Syndrome, Neonatal in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"We report three infants with infantile hemangioma who experienced severe agitation and diarrhea following propranolol administration."8.12Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects. ( Chen, A; Poffenberger, P; Twist, J; Zinn, Z, 2022)
"We report three infants with infantile hemangioma who experienced severe agitation and diarrhea following propranolol administration."4.12Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects. ( Chen, A; Poffenberger, P; Twist, J; Zinn, Z, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Twist, J1
Chen, A1
Poffenberger, P1
Zinn, Z1

Other Studies

1 other study available for propranolol and Abstinence Syndrome, Neonatal

ArticleYear
Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects.
    Pediatric dermatology, 2022, Volume: 39, Issue:2

    Topics: Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Iatrogenic Disease; Infant;

2022